株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

深部脳刺激装置:医療機器のパイプライン評価

Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2016

発行 GlobalData 商品コード 347932
出版日 ページ情報 英文 140 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.37円で換算しております。
Back to Top
深部脳刺激装置:医療機器のパイプライン評価 Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2016
出版日: 2016年12月01日 ページ情報: 英文 140 Pages
概要

当レポートでは、深部脳刺激装置のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 深部脳刺激装置の概要

第3章 開発中の製品

  • 深部脳刺激装置 - パイプライン製品:開発段階別
  • 深部脳刺激装置 - パイプライン製品:地域別
  • 深部脳刺激装置 - パイプライン製品:規制別
  • 深部脳刺激装置 - パイプライン製品:承認予定日別
  • 深部脳刺激装置 - 進行中の臨床試験

第4章 深部脳刺激装置 - 開発中のパイプライン製品:企業別

  • 深部脳刺激装置企業 - パイプライン製品:開発段階別
  • 深部脳刺激装置 - パイプライン製品:開発段階別

第5章 深部脳刺激装置企業と製品の概要

  • Adaptive Neuromodulation GmbH
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Brainsway Ltd.
  • Cerene Biomedics, Inc
  • Children's Hospital Boston
  • Cleveland Medical Devices, Inc.
  • Clinatec
  • Deep Brain Innovations, LLC
  • Duke University
  • Functional Neuromodulation Inc.
  • Highland Instruments, Inc.
  • Massachusetts General Hospital
  • Mayo Clinic.
  • Medtronic plc
  • National Cheng-Kung University Hospital
  • NeuroPro Technologies, Inc.
  • NeuroSigma, Inc.
  • Nuraleve Inc.
  • Soterix Medical Inc
  • St. Jude Medical, Inc.
  • SUNY Downstate Medical Center
  • The University of Utah
  • University of California, Los Angeles
  • University of Central Florida
  • University of Illinois
  • University of Milan
  • University of Oxford
  • University of South Florida
  • Wedge Therapeutics

第6章 深部脳刺激装置 - 最近の動向

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0296EPD

GlobalData's Medical Devices sector report, "Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2016" provides an overview of Deep Brain Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Deep Brain Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 10

2 Introduction 11

  • 2.1 Deep Brain Stimulators Overview 11

3 Products under Development 12

  • 3.1 Deep Brain Stimulators - Pipeline Products by Stage of Development 12
  • 3.2 Deep Brain Stimulators - Pipeline Products by Territory 13
  • 3.3 Deep Brain Stimulators - Pipeline Products by Regulatory Path 14
  • 3.4 Deep Brain Stimulators - Pipeline Products by Estimated Approval Date 15
  • 3.5 Deep Brain Stimulators - Ongoing Clinical Trials 16

4 Deep Brain Stimulators - Pipeline Products under Development by Companies 17

  • 4.1 Deep Brain Stimulators Companies - Pipeline Products by Stage of Development 17
  • 4.2 Deep Brain Stimulators - Pipeline Products by Stage of Development 19

5 Deep Brain Stimulators Companies and Product Overview 21

  • 5.1 Adaptive Neuromodulation GmbH Company Overview 21
    • 5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.2 Aleva Neurotherapeutics SA Company Overview 22
    • 5.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.3 Boston Scientific Corp Company Overview 25
    • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.4 Brainsway Ltd Company Overview 30
    • 5.4.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.5 Cerene Biomedics, Inc. Company Overview 40
    • 5.5.1 Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.6 Cerevast Therapeutics Inc Company Overview 41
    • 5.6.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.7 Children's Hospital Boston Company Overview 42
    • 5.7.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.8 Cleveland Medical Devices Inc Company Overview 43
    • 5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.9 Clinatec Company Overview 44
    • 5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.10 Deep Brain Innovations, LLC Company Overview 45
    • 5.10.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.11 Duke University Company Overview 50
    • 5.11.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.12 Functional Neuromodulation Inc. Company Overview 51
    • 5.12.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.13 Highland Instruments, Inc. Company Overview 53
    • 5.13.1 Highland Instruments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.14 Massachusetts General Hospital Company Overview 54
    • 5.14.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.15 Massachusetts Institute of Technology Company Overview 56
    • 5.15.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.16 Mayo Clinic US Company Overview 57
    • 5.16.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.17 Medtronic plc Company Overview 58
    • 5.17.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.18 National Cheng-Kung University Hospital Company Overview 62
    • 5.18.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.19 NeuroPro Technologies Inc Company Overview 63
    • 5.19.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.20 Neurosigma Inc Company Overview 64
    • 5.20.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.21 Newronika s.r.l. Company Overview 66
    • 5.21.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.22 Nuraleve Inc. Company Overview 67
    • 5.22.1 Nuraleve Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.23 Soterix Medical Inc Company Overview 68
    • 5.23.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.24 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 81
    • 5.24.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 81
  • 5.25 St. Jude Medical Inc Company Overview 83
    • 5.25.1 St. Jude Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • 5.26 SUNY Downstate Medical Center Company Overview 86
    • 5.26.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 86
  • 5.27 The University of Utah Company Overview 87
    • 5.27.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 87
  • 5.28 University of California Los Angeles Company Overview 89
    • 5.28.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 89
  • 5.29 University of Central Florida Company Overview 91
    • 5.29.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.30 University of Illinois Company Overview 93
    • 5.30.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.31 University of Michigan Company Overview 95
    • 5.31.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.32 University of Milan Company Overview 96
    • 5.32.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.33 University of Oxford Company Overview 97
    • 5.33.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 97
  • 5.34 University of South Florida Company Overview 98
    • 5.34.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 98
  • 5.35 Wedge Therapeutics Company Overview 99
    • 5.35.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 99

6 Deep Brain Stimulators- Recent Developments 100

  • 6.1 Nov 28, 2016: Brainsway Reports Continued Financial Growth for Q3 of 2016 100
  • 6.2 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 100
  • 6.3 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 103
  • 6.4 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 103
  • 6.5 Nov 01, 2016: Sheppard Pratt Health System Appoints New Chief Financial Officer 104
  • 6.6 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 104
  • 6.7 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 106
  • 6.8 Oct 13, 2016: Baylor College of Medicine researcher and collaborators awarded grant through NIH BRAIN Initiative 107
  • 6.9 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 108
  • 6.10 Oct 07, 2016: Directional deep brain stimulation for movement disorders now being used 109
  • 6.11 Oct 06, 2016: St. Jude Medical Announces U.S. Launch and First Implant of New Deep Brain Stimulation System and Directional Lead for Patients Suffering from Movement Disorders 110
  • 6.12 Sep 28, 2016: Soterix Medical Launches PainX tDCS Treatment in Canada with Health Canada Approval 110
  • 6.13 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 111
  • 6.14 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 112
  • 6.15 Aug 17, 2016: Jersey Shore University Medical Center is First Hospital In New Jersey to Offer Deep Transcranial Magnetic Stimulation (DTMS) 114
  • 6.16 Aug 03, 2016: Deep Transcranial Magnetic Stimulation Enables Controlled Opening of Blood-Brain Barrier 115
  • 6.17 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 115
  • 6.18 Jul 21, 2016: TGA Hazard Alert On Medtronic Neuromodulation Deep Brain Stimulation system pocket adaptors 117
  • 6.19 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 117
  • 6.20 Jul 19, 2016: Deep Brain Stimulation Continues To Show Promise For Patients With Mild Alzheimer's Disease 119
  • 6.21 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 120
  • 6.22 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 120
  • 6.23 Jun 16, 2016: TGA Hazard Alert on Medtronic deep brain stimulation therapy DBS Extension models 7483 and 37086 120
  • 6.24 Jun 16, 2016: St. Jude Medical Broadens Treatment Options for Patients Suffering Movement Disorders with the European Launch of New Deep Brain Stimulation System and Directional Lead 121
  • 6.25 Jun 15, 2016: Soterix Medical awarded $2.5M NIH grant to run Phase-2 Efficacy Trial to treat Aphasia after Stroke with HD-tDCS 121
  • 6.26 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 122
  • 6.27 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 123
  • 6.28 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 123
  • 6.29 May 27, 2016: Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 126
  • 6.30 May 17, 2016: Soterix Medical, Announces tDCS-LTE Depression Treatment Partnership Program for Clinicians and Medical Centers based on its Non-invasive Neuromodulation Platform 126
  • 6.31 May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 126
  • 6.32 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 127
  • 6.33 Apr 04, 2016: Sheppard Pratt Health System Names New President and CEO 128
  • 6.34 Mar 17, 2016: Medtronic Proposes Proxy Access 128
  • 6.35 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 129
  • 6.36 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 130
  • 6.37 Feb 17, 2016: FDA Approves Medtronic Deep Brain Stimulation for People with Parkinson's Disease with Recent Onset of Motor Complications 130
  • 6.38 Feb 02, 2016: Clinatec Raises USD10.6 Million in Venture Financing 132
  • 6.39 Feb 01, 2016: Aleva Neurotherapeutics Enters into Agreement with Greatbatch 132
  • 6.40 Feb 01, 2016: Aleva Neurotherapeutics to Raise Funds in Series C Financing 132
  • 6.41 Jan 14, 2016: Soterix Medical Launches PainX tDCS Treatment in EU with CE Approval 132
  • 6.42 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 133
  • 6.43 Dec 29, 2015: Soterix Medical Receives CE Mark Approval for 1x1 tDCS Depression Therapy 134
  • 6.44 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 134
  • 6.45 Dec 09, 2015: Medtronic Announces FDA Approval for the Only Full-Body MR Conditional Deep Brain Stimulation Systems 135

7 Appendix 137

  • 7.1 Methodology 137
  • 7.2 About GlobalData 140
  • 7.3 Contact Us 140
  • 7.4 Disclaimer 140

List of Tables

  • Table 1: Deep Brain Stimulators - Pipeline Products by Stage of Development 12
  • Table 2: Deep Brain Stimulators - Pipeline Products by Territory 13
  • Table 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path 14
  • Table 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date 15
  • Table 5: Deep Brain Stimulators - Ongoing Clinical Trials 16
  • Table 6: Deep Brain Stimulators Companies - Pipeline Products by Stage of Development 17
  • Table 7: Deep Brain Stimulators - Pipeline Products by Stage of Development 19
  • Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 9: CR-Capable Implant - Product Status 21
  • Table 10: CR-Capable Implant - Product Description 21
  • Table 11: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 12: directSTIM - Product Status 22
  • Table 13: directSTIM - Product Description 23
  • Table 14: spiderSTIM - Product Status 23
  • Table 15: spiderSTIM - Product Description 23
  • Table 16: Aleva Neurotherapeutics SA - Ongoing Clinical Trials Overview 24
  • Table 17: spiderSTIM - Evaluation of Directional Recording and Stimulation Using the spiderSTN During the Implantation of DBS Leads 24
  • Table 18: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 19: Directional Lead - Product Status 25
  • Table 20: Directional Lead - Product Description 26
  • Table 21: Enspire DBS Therapy System - Stroke - Product Status 26
  • Table 22: Enspire DBS Therapy System - Stroke - Product Description 26
  • Table 23: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status 27
  • Table 24: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description 27
  • Table 25: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Status 27
  • Table 26: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Description 28
  • Table 27: Boston Scientific Corp - Ongoing Clinical Trials Overview 28
  • Table 28: Vercise Deep Brain Stimulation System - Parkinson's Disease - Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation 29
  • Table 29: Vercise Deep Brain Stimulation System - Parkinson's Disease - Implantable Neurostimulator for the Treatment of Parkinson's Disease 29
  • Table 30: Vercise Deep Brain Stimulation System - Parkinson's Disease - Registry of Deep Brain Stimulation with the VERCISE System: Vercise DBS Registry 29
  • Table 31: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 32: Deep TMS System - Alzheimer's Disease - Product Status 30
  • Table 33: Deep TMS System - Alzheimer's Disease - Product Description 31
  • Table 34: Deep TMS System - Autism - Product Status 31
  • Table 35: Deep TMS System - Autism - Product Description 31
  • Table 36: Deep TMS System - Bipolar Disorder - Product Status 32
  • Table 37: Deep TMS System - Bipolar Disorder - Product Description 32
  • Table 38: Deep TMS System - Multiple Sclerosis - Product Status 32
  • Table 39: Deep TMS System - Multiple Sclerosis - Product Description 33
  • Table 40: Deep TMS System - Obsessive Compulsive Disorder - Product Status 33
  • Table 41: Deep TMS System - Obsessive Compulsive Disorder - Product Description 33
  • Table 42: Deep TMS System - PTSD - Product Status 34
  • Table 43: Deep TMS System - PTSD - Product Description 34
  • Table 44: Deep TMS System - Smoking Cessation - Product Status 34
  • Table 45: Deep TMS System - Smoking Cessation - Product Description 35
  • Table 46: Deep TMS System - Stroke - Product Status 35
  • Table 47: Deep TMS System - Stroke - Product Description 35
  • Table 48: Brainsway Ltd - Ongoing Clinical Trials Overview 36
  • Table 49: Deep TMS System - Bipolar Disorder - Evaluation Clinical, Cognitive and Safety in the Treatment of Bipolar Depression with H1-Coil Deep Transcranial Magnetic Stimulation 36
  • Table 50: Deep TMS System - Smoking Cessation - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) (with the H-ADD Coil) Intended as an Aid to Smoking Cessation 37
  • Table 51: Deep TMS System - PTSD - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-traumatic Stress Disorder (PTSD) 38
  • Table 52: Deep TMS System - PTSD - Multi-center Investigational Device Exemption Study of Brainsway's Deep Transcranial Magnetic Stimulation for Treatment of Post Traumatic Stress Disorder 38
  • Table 53: Deep TMS System - Obsessive Compulsive Disorder - Tolerability, Safety and Efficacy of the HAC-coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects 39
  • Table 54: Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 55: Implantable Cooling Therapy Device - Product Status 40
  • Table 56: Implantable Cooling Therapy Device - Product Description 40
  • Table 57: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 58: Neurosonx SR - Product Status 41
  • Table 59: Neurosonx SR - Product Description 41
  • Table 60: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 61: rTMS H-Coil - Product Status 42
  • Table 62: rTMS H-Coil - Product Description 42
  • Table 63: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 64: ParkinTune - Product Status 43
  • Table 65: ParkinTune - Product Description 43
  • Table 66: Clinatec Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 67: Intracranial Deep Brain Stimulation Device - Product Status 44
  • Table 68: Intracranial Deep Brain Stimulation Device - Product Description 44
  • Table 69: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 70: TOPS Device - Alzheimer's disease - Product Status 45
  • Table 71: TOPS Device - Alzheimer's disease - Product Description 45
  • Table 72: TOPS Device - Depression - Product Status 46
  • Table 73: TOPS Device - Depression - Product Description 46
  • Table 74: TOPS Device - Epilepsy - Product Status 46
  • Table 75: TOPS Device - Epilepsy - Product Description 47
  • Table 76: TOPS Device - Obesity - Product Status 47
  • Table 77: TOPS Device - Obesity - Product Description 47
  • Table 78: TOPS Device - Obsessive-Compulsive Disorder - Product Status 48
  • Table 79: TOPS Device - Obsessive-Compulsive Disorder - Product Description 48
  • Table 80: TOPS Device - Parkinson's disease - Product Status 48
  • Table 81: TOPS Device - Parkinson's disease - Product Description 49
  • Table 82: Duke University Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 83: DBS Electrode - Product Status 50
  • Table 84: DBS Electrode - Product Description 50
  • Table 85: Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 86: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Status 51
  • Table 87: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Description 51
  • Table 88: Functional Neuromodulation Inc. - Ongoing Clinical Trials Overview 52
  • Table 89: Deep Brain Stimulation - Mild Alzheimer's Disease - A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients with Mild Probable Alzheimer's Disease 52
  • Table 90: Highland Instruments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 91: ESStim - Parkinson's Disease - Product Status 53
  • Table 92: ESStim - Parkinson's Disease - Product Description 53
  • Table 93: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 94: Deep Brain Stimulation Device - Product Status 54
  • Table 95: Deep Brain Stimulation Device - Product Description 54
  • Table 96: Deep Brain Stimulation System - Product Status 55
  • Table 97: Deep Brain Stimulation System - Product Description 55
  • Table 98: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 99: Implantable Micro - Cannula Device - Product Status 56
  • Table 100: Implantable Micro - Cannula Device - Product Description 56
  • Table 101: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 102: Sensor System - DBS - Product Status 57
  • Table 103: Sensor System - DBS - Product Description 57
  • Table 104: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 105: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Status 58
  • Table 106: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Description 59
  • Table 107: Reclaim Deep Brain Stimulation System - Depression - Product Status 59
  • Table 108: Reclaim Deep Brain Stimulation System - Depression - Product Description 59
  • Table 109: Sapiens DBS Field Steering System - Product Status 60
  • Table 110: Sapiens DBS Field Steering System - Product Description 60
  • Table 111: Medtronic plc - Ongoing Clinical Trials Overview 60
  • Table 112: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Medtronic Registry for Epilepsy (MORE) 61
  • Table 113: National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 114: Responsive Epilepsy Control System-On-Chip - Product Status 62
  • Table 115: Responsive Epilepsy Control System-On-Chip - Product Description 62
  • Table 116: NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 117: Deep Brain Stimulation - Product Status 63
  • Table 118: Deep Brain Stimulation - Product Description 63
  • Table 119: Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 120: Deep Brain Stimulation System - Cachexia - Product Status 64
  • Table 121: Deep Brain Stimulation System - Cachexia - Product Description 64
  • Table 122: Deep Brain Stimulation System - Obesity - Product Status 65
  • Table 123: Deep Brain Stimulation System - Obesity - Product Description 65
  • Table 124: Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 125: Implantable Deep Brain Stimulation Device - Product Status 66
  • Table 126: Implantable Deep Brain Stimulation Device - Product Description 66
  • Table 127: Nuraleve Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 128: SmartStim M200 Device - Product Status 67
  • Table 129: SmartStim M200 Device - Product Description 67
  • Table 130: Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 131: 1×1 tDCS Device - Product Status 68
  • Table 132: 1×1 tDCS Device - Product Description 69
  • Table 133: HD-tDCS Platform - Product Status 69
  • Table 134: HD-tDCS Platform - Product Description 70
  • Table 135: PainX tDCS System - Product Status 70
  • Table 136: PainX tDCS System - Product Description 71
  • Table 137: Soterix Medical Inc - Ongoing Clinical Trials Overview 72
  • Table 138: HD-tDCS Platform - Association of Transcranial Direct Current Stimulation (tDCS) with Gait Training with Partial Body Weight Support on the Robotic Device (Lokomat) for Treatment of Patients with Incomplete Spinal Cord Injury 74
  • Table 139: HD-tDCS Platform - High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy 74
  • Table 140: HD-tDCS Platform - Targeted Transcranial Electrotherapy for Stroke Rehabilitation - Exploratory Trial on Aphasia 74
  • Table 141: 1×1 tDCS Device - Boston-Harvard Burn Injury Model System: Cortical Modulation with Transcranial Direct Current Stimulation (tDCS) for Neuropathic Symptoms Following Burn Injury 75
  • Table 142: 1×1 tDCS Device - Effects of Transcranial Direct Current Stimulation (tDCS) in Spoken and Written Production in Primary Progressive Aphasia (PPA) 75
  • Table 143: 1×1 tDCS Device - Escitalopram and Transcranial Direct Current Stimulation in Major Depressive Disorder: A Double-blind, Placebo-controlled, Randomized, Non-inferiority Trial 75
  • Table 144: 1×1 tDCS Device - Evaluating Anodal tDCS Preceding Aphasia Therapy 76
  • Table 145: 1×1 tDCS Device - Home-Administered Transcranial Direct Current Stimulation (tDCS) Treatment for Depression 76
  • Table 146: 1×1 tDCS Device - Neural Correlates of Pain-related Cognitive Processing in Chronic Pain of the Cornea: An ERP and Electrical Stimulation Study 76
  • Table 147: 1×1 tDCS Device - Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS) 77
  • Table 148: 1×1 tDCS Device - Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment 77
  • Table 149: 1×1 tDCS Device - Spaulding-Harvard Spinal Cord Injury (SH-SCI) Study: Effects of tDCS on Chronic Pain in Spinal Cord Injury 78
  • Table 150: 1×1 tDCS Device - tDCS and Aphasia Treatment 78
  • Table 151: 1×1 tDCS Device - The Influence of tDSC on the Arm and Hand Function in Stroke Patients 78
  • Table 152: 1×1 tDCS Device - Transcranial Direct Current Stimulation for Hallucinations in First-episode Schizophrenia 79
  • Table 153: 1×1 tDCS Device - Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment 79
  • Table 154: PainX tDCS System - Predicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees 80
  • Table 155: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 156: Implantable Electrode - Epilepsy Surgery - Product Status 81
  • Table 157: Implantable Electrode - Epilepsy Surgery - Product Description 81
  • Table 158: Indigenous Deep Brain Stimulation Device - Product Status 82
  • Table 159: Indigenous Deep Brain Stimulation Device - Product Description 82
  • Table 160: St. Jude Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 161: Libra Deep Brain Stimulation System - Depression - Product Status 83
  • Table 162: Libra Deep Brain Stimulation System - Depression - Product Description 84
  • Table 163: Next Generation Implantable DBS System - Primary Cell - Product Status 84
  • Table 164: Next Generation Implantable DBS System - Primary Cell - Product Description 84
  • Table 165: St. Jude Medical Inc - Ongoing Clinical Trials Overview 85
  • Table 166: Libra Deep Brain Stimulation System - Depression - A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression 85
  • Table 167: Libra Deep Brain Stimulation System - Depression - Deep Brain Stimulation for Treatment-Resistant Depression 85
  • Table 168: SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 169: Low-Frequency Sine Wave Neurostimulation Therapy Device - Product Status 86
  • Table 170: Low-Frequency Sine Wave Neurostimulation Therapy Device - Product Description 86
  • Table 171: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 172: DBS10k - Product Status 87
  • Table 173: DBS10k - Product Description 87
  • Table 174: Neural Recording Array - Product Status 88
  • Table 175: Neural Recording Array - Product Description 88
  • Table 176: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 177: Implantable Ultrasound Neuromodulation Device - Product Status 89
  • Table 178: Implantable Ultrasound Neuromodulation Device - Product Description 89
  • Table 179: Wireless Deep Brain Stimulating System - Product Status 90
  • Table 180: Wireless Deep Brain Stimulating System - Product Description 90
  • Table 181: University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 182: Deep Brain Stimulation System - Product Status 91
  • Table 183: Deep Brain Stimulation System - Product Description 92
  • Table 184: University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 185: Wireless Deep Brain Stimulation System - Essential Tremor - Product Status 93
  • Table 186: Wireless Deep Brain Stimulation System - Essential Tremor - Product Description 94
  • Table 187: Wireless Deep Brain Stimulation System - Parkinson's Disease - Product Status 94
  • Table 188: Wireless Deep Brain Stimulation System - Parkinson's Disease - Product Description 94
  • Table 189: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 190: Deep Brain Stimulation System - Product Status 95
  • Table 191: Deep Brain Stimulation System - Product Description 95
  • Table 192: University of Milan Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 193: Implantable Brain Pacemaker - Product Status 96
  • Table 194: Implantable Brain Pacemaker - Product Description 96
  • Table 195: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 196: Adaptive Deep Brain Stimulation System - Product Status 97
  • Table 197: Adaptive Deep Brain Stimulation System - Product Description 97
  • Table 198: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 98
  • Table 199: Deep Brain Stimulator - Product Status 98
  • Table 200: Deep Brain Stimulator - Product Description 98
  • Table 201: Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 99
  • Table 202: SONS System - Product Status 99
  • Table 203: SONS System - Product Description 99
  • Table 204: Glossary 138

List of Figures

  • Figure 1: Deep Brain Stimulators - Pipeline Products by Stage of Development 12
  • Figure 2: Deep Brain Stimulators - Pipeline Products by Territory 13
  • Figure 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path 14
  • Figure 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date 15
  • Figure 5: Deep Brain Stimulators - Ongoing Clinical Trials 16
Back to Top